Epperly Melissa B,
SEC Form 4 insider trading activity
Epperly Melissa B, has filed 11 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.
On the most recent filing, Epperly Melissa B, is listed as Director at Roivant Sciences Ltd. Inside the rolling window, Epperly Melissa B, reported no open-market purchases and 4 open-market sales totaling $2.6M in ROIV. The largest disclosed transaction in the window is a sale of 41,861 ROIV shares on Mar 16, 2026, worth $1.2M.
Companies traded
Other insiders at ROIV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Epperly Melissa B, made?
Epperly Melissa B, has filed 11 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.
Which companies does Epperly Melissa B, trade?
Epperly Melissa B, has filed SEC Form 4 disclosures for 1 company, including ROIV.
When was Epperly Melissa B,'s most recent SEC Form 4 filing?
Epperly Melissa B,'s most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.
What is Epperly Melissa B,'s total buy and sell value in the current window?
Inside the rolling retention window, Epperly Melissa B, bought $0 and sold $2.6M based on SEC Form 4 filings.
What was Epperly Melissa B,'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 41,861 ROIV shares on 2026-03-16, worth $1.2M, per SEC Form 4 filings.